Pet business drives Virbac’s performance in Q1
A recent acquisition in the feline segment contributes to growth, while supply chain risks remain contained for the rest of the fiscal year.
French animal health pharmaceutical firm Virbac reported revenue of €384 million ($414M) for the first quarter of fiscal year (FY) 2026, ending 31 March 2026.
According to th…
Did you think it would be this easy? Nope! Just register. It’s free! Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut cursus turpis vel cursus ullamcorper. Sed ante mi, finibus eget porttitor a, tincidunt ac dolor. Vivamus ornare semper lorem, consequat commodo lectus elementum vitae. Cras id mattis urna. Donec rutrum dignissim lacinia. Duis ultricies sapien at ipsum tincidunt.
Sed in iaculis elit, sit amet convallis felis. Pellentesque non justo lectus. Donec sollicitudin lorem in sapien euismod varius at vitae mi. Maecenas ut elit ac risus consectetur vulputate. Praesent vel orci ante. Curabitur egestas dapibus nisi ac laoreet. Nullam a lacinia libero, non fringilla nisl.
You’re out of free articles,
register for unlimited access
Share this story:
One click prioritizes GlobalPETS in your search results and AI answers.
